Business Description
Guangdong VTR Bio-Tech Co Ltd
ISIN : CNE100001RJ8
Share Class Description:
SZSE:300381: Class ACompare
Compare
Traded in other countries / regions
300381.China IPO Date
2014-01-28Description
Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme, and others. It sells its products in China, and also exports it to various other countries.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.82 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 2.92 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.1 | |||||
| Beneish M-Score | -2.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.5 | |||||
| 3-Year EBITDA Growth Rate | -36.5 | |||||
| 3-Year Book Growth Rate | -4.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.67 | |||||
| 9-Day RSI | 71.54 | |||||
| 14-Day RSI | 65.91 | |||||
| 3-1 Month Momentum % | 42.13 | |||||
| 6-1 Month Momentum % | 22.44 | |||||
| 12-1 Month Momentum % | 5.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.78 | |||||
| Quick Ratio | 5.03 | |||||
| Cash Ratio | 3.82 | |||||
| Days Inventory | 154.41 | |||||
| Days Sales Outstanding | 95.78 | |||||
| Days Payable | 68.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.76 | |||||
| Dividend Payout Ratio | 60 | |||||
| 3-Year Dividend Growth Rate | 18.6 | |||||
| Forward Dividend Yield % | 0.76 | |||||
| 5-Year Yield-on-Cost % | 1.86 | |||||
| Shareholder Yield % | 1.46 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.96 | |||||
| Operating Margin % | -0.58 | |||||
| Net Margin % | 2.45 | |||||
| FCF Margin % | -32.75 | |||||
| ROE % | 0.75 | |||||
| ROA % | 0.66 | |||||
| ROIC % | -0.24 | |||||
| 3-Year ROIIC % | 13.48 | |||||
| ROC (Joel Greenblatt) % | 2.42 | |||||
| ROCE % | 1.14 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 210 | |||||
| PE Ratio without NRI | 8400 | |||||
| Shiller PE Ratio | 49.41 | |||||
| PS Ratio | 5.12 | |||||
| PB Ratio | 1.56 | |||||
| Price-to-Tangible-Book | 1.82 | |||||
| Price-to-Operating-Cash-Flow | 20.69 | |||||
| EV-to-EBIT | 97.59 | |||||
| EV-to-EBITDA | 97.59 | |||||
| EV-to-Revenue | 3.82 | |||||
| EV-to-FCF | -11.56 | |||||
| Price-to-GF-Value | 1.55 | |||||
| Price-to-Projected-FCF | 2.18 | |||||
| Price-to-Median-PS-Value | 1.6 | |||||
| Price-to-Graham-Number | 26.25 | |||||
| Price-to-Net-Current-Asset-Value | 3.98 | |||||
| Price-to-Net-Cash | 7.24 | |||||
| Earnings Yield (Greenblatt) % | 1.02 | |||||
| FCF Yield % | -6.39 | |||||
| Forward Rate of Return (Yacktman) % | -0.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangdong VTR Bio-Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 803.067 | ||
| EPS (TTM) (Â¥) | 0.04 | ||
| Beta | 1.43 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.27 | ||
| Volatility % | 55.99 | ||
| 14-Day RSI | 65.91 | ||
| 14-Day ATR (Â¥) | 0.319467 | ||
| 20-Day SMA (Â¥) | 7.747 | ||
| 12-1 Month Momentum % | 5.17 | ||
| 52-Week Range (Â¥) | 3.53 - 9.79 | ||
| Shares Outstanding (Mil) | 490.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangdong VTR Bio-Tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangdong VTR Bio-Tech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guangdong VTR Bio-Tech Co Ltd Frequently Asked Questions
What is Guangdong VTR Bio-Tech Co Ltd(SZSE:300381)'s stock price today?
The current price of SZSE:300381 is ¥8.32. The 52 week high of SZSE:300381 is ¥9.79 and 52 week low is ¥3.53.
When is next earnings date of Guangdong VTR Bio-Tech Co Ltd(SZSE:300381)?
The next earnings date of Guangdong VTR Bio-Tech Co Ltd(SZSE:300381) is .
Does Guangdong VTR Bio-Tech Co Ltd(SZSE:300381) pay dividends? If so, how much?
The Dividend Yield %  of Guangdong VTR Bio-Tech Co Ltd(SZSE:300381) is 0.76% (As of Today), Highest Dividend Payout Ratio of Guangdong VTR Bio-Tech Co Ltd(SZSE:300381) was 60. The lowest was 0.25. And the median was 0.37. The  Forward Dividend Yield % of Guangdong VTR Bio-Tech Co Ltd(SZSE:300381) is 0.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers